key: cord-1053926-ljla2fyk
authors: Arachchillage, Deepa R. J.; Laffan, Mike
title: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
date: 2020-04-29
journal: J Thromb Haemost
DOI: 10.1111/jth.14820
sha: c81d82053b176fe94840dd22a994d38578ee4a76
doc_id: 1053926
cord_uid: ljla2fyk

Recently published article by Dr Tang and colleagues on ''Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia'' highlighted that disseminated intravascular coagulation is common severe respiratory failure patients with Covid 191 . Novel Coronavirus (Covid-19) infection leading to pneumonia and severe acute respiratory distress syndrome (ARDS) was first reported in Wuhan, Hubei Province, China and has subsequently spread to almost all other countries in the world. On 11/03/2020, WHO declared the Covid-19 outbreak a global pandemic.

Interestingly, thrombocytopenia does not seem to be common and was present in only 37/201(18.8%) compared with >50% patients presenting with ARDS from other causes such as bacterial and other viral infections. 4 We would like to highlight the implications of Coagulation abnormalities associated with Covid-19 in patients receiving venovenous extracorporeal membrane oxygenation (VV-ECMO) as the high proportion of Covid-19 patients developing ARDS means that many will also require VV-ECMO. We have previously reported on the high frequency of intracranial hemorrhage in patients receiving VV-ECMO and so the high frequency in COVID19 is of concern. 5 However, the lack of thrombocytopenia may be beneficial as we found this to be a risk factor for ICH. 5 The studies cited here have led to suggestions that DIC may be a useful prognostic marker, but the anticoagulation required for VV-ECMO and the activation of coagulation from artificial surfaces may confound interpretation. In particular, a sudden rise in D-dimer may be because of pump head thrombosis.

In summary, patients with severe Covid-19 are at greater risk of DIC, which may be further complicated by the effects of the ECMO circuit and the combination may increase thrombo-hemorrhagic morbidity. We expect that careful interpretation of coagulation abnormalities and systemic anticoagulation will be required, and standard protocols may need adapting to this new disorder. Overt disseminated intravascular coagulation ≥ 5

Note: Adapted from Taylor et al. 3 

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score

Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure